(Q46890647)

26 December 2017

title

Properties of a selective kappa agonist, U-50,488H (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

11 August 2023

author name string

VonVoigtlander PF

2

1 reference

26 December 2017

R. A. Lahti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6131357

11 August 2023

P. F. VonVoigtlander

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6131357

11 August 2023

C. Barsuhn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6131357

11 August 2023

language of work or name

English

0 references

publication date

1 November 1982

1 reference

26 December 2017

15 November 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6131357

full work available at URL

11 August 2023

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0024320582901321?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

https://api.elsevier.com/content/article/PII:0024320582901321?httpAccept=text/plain

11 August 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

11 August 2023

1 reference

26 December 2017

volume

31

1 reference

26 December 2017

page(s)

2257-2260

1 reference

26 December 2017

issue

20-21

1 reference

26 December 2017

Journal of Pharmacology and Experimental Therapeutics

cites work

1

197

517

Martin

1976

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

Journal of Pharmacology and Experimental Therapeutics

11 August 2023

2

192

494

McGilliard

1978

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

Chronic naloxone results in prolonged increases in opiate binding sites in brain

11 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

11 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

Bremazocine: A potent, long-acting opiate kappa-agonist

11 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

3H-ethylketocyclazocine binding: Lack of evidence for a separate κ receptor in rats CNS

11 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

High affinity binding of [3H]ethylketocyclazocine to rat brain homogenate

11 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

11 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(82)90132-1

11 August 2023

Identifiers

1 reference

26 December 2017

1 reference

26 December 2017